DK162233C - Fremgangsmaade til isolering af faktor viii fra blodplasma og pharmaceutisk praeparat indeholdende den saaledes isolerede fator viii - Google Patents

Fremgangsmaade til isolering af faktor viii fra blodplasma og pharmaceutisk praeparat indeholdende den saaledes isolerede fator viii

Info

Publication number
DK162233C
DK162233C DK562189A DK562189A DK162233C DK 162233 C DK162233 C DK 162233C DK 562189 A DK562189 A DK 562189A DK 562189 A DK562189 A DK 562189A DK 162233 C DK162233 C DK 162233C
Authority
DK
Denmark
Prior art keywords
viii
blood plasma
phatar
factor viii
procedure
Prior art date
Application number
DK562189A
Other languages
Danish (da)
English (en)
Other versions
DK162233B (da
DK562189A (da
DK562189D0 (da
Inventor
Per Kaersgaard
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of DK562189D0 publication Critical patent/DK562189D0/da
Priority to DK562189A priority Critical patent/DK162233C/da
Priority to ZA908599A priority patent/ZA908599B/xx
Priority to CS905371A priority patent/CZ537190A3/cs
Priority to SK5371-90A priority patent/SK537190A3/sk
Priority to SU905052211A priority patent/RU2055593C1/ru
Priority to CA002073012A priority patent/CA2073012C/fr
Priority to DE69017050T priority patent/DE69017050T2/de
Priority to UA94020494A priority patent/UA29421C2/uk
Priority to JP3500067A priority patent/JP2509407B2/ja
Priority to AU67470/90A priority patent/AU631471B2/en
Priority to PCT/DK1990/000279 priority patent/WO1991007438A1/fr
Priority to AT90917201T priority patent/ATE118508T1/de
Priority to HU9201551A priority patent/HU214905B/hu
Priority to EP90917201A priority patent/EP0524172B1/fr
Priority to ES90917201T priority patent/ES2068404T3/es
Priority to YU210590A priority patent/YU47524B/sh
Priority to US07/610,480 priority patent/US5245014A/en
Priority to NZ236004A priority patent/NZ236004A/xx
Priority to SI9012105A priority patent/SI9012105A/sl
Priority to IE402290A priority patent/IE66836B1/en
Priority to IL9627790A priority patent/IL96277A/en
Priority to PT95830A priority patent/PT95830B/pt
Priority to CN90109030A priority patent/CN1044121C/zh
Priority to PL90287703A priority patent/PL164894B1/pl
Publication of DK562189A publication Critical patent/DK562189A/da
Publication of DK162233B publication Critical patent/DK162233B/da
Application granted granted Critical
Publication of DK162233C publication Critical patent/DK162233C/da
Priority to NO921839A priority patent/NO180741C/no
Priority to BG96316A priority patent/BG61231B1/bg
Priority to FI922105A priority patent/FI103510B1/fi
Priority to HRP-2105/90A priority patent/HRP930277A2/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Amplifiers (AREA)
  • Networks Using Active Elements (AREA)
  • Housing For Livestock And Birds (AREA)
  • Cephalosporin Compounds (AREA)
  • External Artificial Organs (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Separation By Low-Temperature Treatments (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK562189A 1989-11-09 1989-11-09 Fremgangsmaade til isolering af faktor viii fra blodplasma og pharmaceutisk praeparat indeholdende den saaledes isolerede fator viii DK162233C (da)

Priority Applications (28)

Application Number Priority Date Filing Date Title
DK562189A DK162233C (da) 1989-11-09 1989-11-09 Fremgangsmaade til isolering af faktor viii fra blodplasma og pharmaceutisk praeparat indeholdende den saaledes isolerede fator viii
ZA908599A ZA908599B (en) 1989-11-09 1990-10-26 A method for isolating biologically active compounds
CS905371A CZ537190A3 (cs) 1989-11-09 1990-11-01 Způsob izolování faktoru VIII
SK5371-90A SK537190A3 (en) 1989-11-09 1990-11-01 Method of the factor viii isolation
ES90917201T ES2068404T3 (es) 1989-11-09 1990-11-05 Un metodo para aislar el factor viii.
CA002073012A CA2073012C (fr) 1989-11-09 1990-11-05 Methode d'isolement du facteur viii
DE69017050T DE69017050T2 (de) 1989-11-09 1990-11-05 Verfahren zur isolierung von faktor viii.
UA94020494A UA29421C2 (uk) 1989-11-09 1990-11-05 Спосіб виділення фактора vііі з інших білків в плазмі крові
JP3500067A JP2509407B2 (ja) 1989-11-09 1990-11-05 生物学的に活性な化合物の単離方法
AU67470/90A AU631471B2 (en) 1989-11-09 1990-11-05 A method for isolating factor viii
PCT/DK1990/000279 WO1991007438A1 (fr) 1989-11-09 1990-11-05 Procede d'isolation du facteur viii
AT90917201T ATE118508T1 (de) 1989-11-09 1990-11-05 Verfahren zur isolierung von faktor viii.
HU9201551A HU214905B (hu) 1989-11-09 1990-11-05 Eljárás VIII. faktor izolálására
EP90917201A EP0524172B1 (fr) 1989-11-09 1990-11-05 Procede d'isolation du facteur viii
SU905052211A RU2055593C1 (ru) 1989-11-09 1990-11-05 Способ выделения фактора viii из других белков в плазме крови
NZ236004A NZ236004A (en) 1989-11-09 1990-11-07 Isolation of factor viii using gel filtration
US07/610,480 US5245014A (en) 1989-11-09 1990-11-07 Method for isolating factors viii from plasma by gel filtration chromatography under group separation conditions
YU210590A YU47524B (sh) 1989-11-09 1990-11-07 Postupak za izolovanje faktora viii iz drugih proteina u krvnoj plazmi
SI9012105A SI9012105A (sl) 1989-11-09 1990-11-07 Postopek za izoliranje biološko aktivnih spoji
IE402290A IE66836B1 (en) 1989-11-09 1990-11-08 A method for isolating biologically active compounds
IL9627790A IL96277A (en) 1989-11-09 1990-11-08 Method for isolating factor IIIV
PT95830A PT95830B (pt) 1989-11-09 1990-11-08 Processo para o isolamento do factor viii sob a forma de uma fraccao pura directamente de plasma mediante filtracao em gel
CN90109030A CN1044121C (zh) 1989-11-09 1990-11-09 分离凝血因子viii配合物的方法
PL90287703A PL164894B1 (pl) 1989-11-09 1990-11-09 Sposób izolowania c zynnika krzepniecia VIII PL PL PL PL PL PL PL PL
FI922105A FI103510B1 (fi) 1989-11-09 1992-05-08 Menetelmä tekijän VIII eristämiseksi
BG96316A BG61231B1 (en) 1989-11-09 1992-05-08 A method for isolating factor viii
NO921839A NO180741C (no) 1989-11-09 1992-05-08 Fremgangsmåte for isolering av Faktor VIII
HRP-2105/90A HRP930277A2 (en) 1989-11-09 1993-03-08 A method for isolating biologically active compounds

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK562189 1989-11-09
DK562189A DK162233C (da) 1989-11-09 1989-11-09 Fremgangsmaade til isolering af faktor viii fra blodplasma og pharmaceutisk praeparat indeholdende den saaledes isolerede fator viii

Publications (4)

Publication Number Publication Date
DK562189D0 DK562189D0 (da) 1989-11-09
DK562189A DK562189A (da) 1991-05-10
DK162233B DK162233B (da) 1991-09-30
DK162233C true DK162233C (da) 1992-03-16

Family

ID=8144000

Family Applications (1)

Application Number Title Priority Date Filing Date
DK562189A DK162233C (da) 1989-11-09 1989-11-09 Fremgangsmaade til isolering af faktor viii fra blodplasma og pharmaceutisk praeparat indeholdende den saaledes isolerede fator viii

Country Status (26)

Country Link
US (1) US5245014A (fr)
EP (1) EP0524172B1 (fr)
JP (1) JP2509407B2 (fr)
CN (1) CN1044121C (fr)
AT (1) ATE118508T1 (fr)
AU (1) AU631471B2 (fr)
BG (1) BG61231B1 (fr)
CA (1) CA2073012C (fr)
CZ (1) CZ537190A3 (fr)
DE (1) DE69017050T2 (fr)
DK (1) DK162233C (fr)
ES (1) ES2068404T3 (fr)
FI (1) FI103510B1 (fr)
HU (1) HU214905B (fr)
IE (1) IE66836B1 (fr)
IL (1) IL96277A (fr)
NO (1) NO180741C (fr)
NZ (1) NZ236004A (fr)
PL (1) PL164894B1 (fr)
PT (1) PT95830B (fr)
RU (1) RU2055593C1 (fr)
SK (1) SK537190A3 (fr)
UA (1) UA29421C2 (fr)
WO (1) WO1991007438A1 (fr)
YU (1) YU47524B (fr)
ZA (1) ZA908599B (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2042138T3 (es) * 1989-05-24 1993-12-01 Miles Inc. Filtracion en gel del factor viii tratado termicamente.
US5859204A (en) * 1992-04-07 1999-01-12 Emory University Modified factor VIII
US6180371B1 (en) 1996-06-26 2001-01-30 Emory University Modified factor VIII
US5888974A (en) * 1992-04-07 1999-03-30 Emory University Hybrid human/animal factor VIII
US5659017A (en) * 1995-11-07 1997-08-19 Alpha Therapeutic Corporation Anion exchange process for the purification of Factor VIII
US7560107B2 (en) 1996-06-26 2009-07-14 Emory University Modified factor VIII
US6458563B1 (en) 1996-06-26 2002-10-01 Emory University Modified factor VIII
US6531577B1 (en) * 1997-12-15 2003-03-11 Hemasure Denmark A/S von Willebrand factor (vWF)-containing preparation, process for preparing vWF-containing preparations, and use of such preparations
US6290527B1 (en) * 1998-07-03 2001-09-18 Nippon Telegraph And Telephone Corp. Nippon telegraph and telephone corporation
US6586573B1 (en) 1999-02-22 2003-07-01 Baxter International Inc. Albumin-free Factor VIII formulations
JP2002348300A (ja) * 1999-04-12 2002-12-04 Fujimori Kogyo Co Ltd 血液凝固第ｖｉｉｉ因子および血液凝固第ｖｉｉｉ因子／フォン・ビルブラント因子複合体の精製方法
AUPR638801A0 (en) * 2001-07-13 2001-08-09 Life Therapeutics Limited Factor viii separation
ES2449044T3 (es) 2004-05-03 2014-03-18 Emory University Procedimiento de administración de fVIII sin dominio B porcino
CN101010333B (zh) * 2004-08-27 2013-08-14 诺和诺德医疗保健公司 从生物材料中纯化凝血因子xⅲ多肽
US20060226086A1 (en) * 2005-04-08 2006-10-12 Robinson Thomas C Centrifuge for blood processing systems
AU2009313325B2 (en) * 2008-11-07 2014-05-01 Takeda Pharmaceutical Company Limited Factor VIII formulations
BR112012024550B1 (pt) * 2010-03-30 2020-12-08 Octapharma Ag processo de produção de uma proteína dependente de vitamina k livre de príons em uma sequência de purificação que emprega cromatografia
RU2445974C2 (ru) * 2010-04-26 2012-03-27 Учреждение Российской академии медицинских наук Гематологический научный центр ГНЦ РАМН Способ получения концентрата фактора viii из плазмы крови человека
KR101948337B1 (ko) 2010-11-05 2019-02-14 박스알타 인코퍼레이티드 증가된 특이 활성도를 갖는 항혈우병 인자 ｖｉｉｉ의 신규 변이체
CA2821711C (fr) 2010-12-15 2017-10-10 Baxter International Inc. Recuperation d'eluat par utilisation d'un gradient de conductivite
CN103506080A (zh) * 2012-06-19 2014-01-15 汪志友 一种用于分离纯化凝血因子viii的介质及其制备方法
CA2886326C (fr) * 2012-09-28 2021-11-02 Chugai Seiyaku Kabushiki Kaisha Procede d'evaluation de reaction de coagulation du sang
US9663553B2 (en) 2014-01-29 2017-05-30 Hemarus Therapeutics Limited Integrated process for the production of therapeutics (human albumin, immunoglobulins, clotting factor VIII and clotting factor IX) from human plasma

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4495175A (en) * 1982-08-05 1985-01-22 University Of Rochester Preparation of highly purified human antihemophilic factor
US4543210A (en) * 1984-10-04 1985-09-24 Miles Laboratories, Inc. Process for producing a high purity antihemophilic factor concentrate
DK525384D0 (da) * 1984-11-05 1984-11-05 Nordisk Insulinlab Praeparat paa basis af faktor viii til behandling af haemofili a inhibitorpatienter samt fremgangsmaade til fremstilling af et saadan praeparat
US4847362A (en) * 1985-02-01 1989-07-11 New York University Method for purifying antihemophilic factor
US4675385A (en) * 1985-03-27 1987-06-23 Alpha Therapeutic Corporation Isolation of human plasma procoagulant protein factor VIII from biological factors
US4758657A (en) * 1985-07-11 1988-07-19 Armour Pharmaceutical Company Method of purifying Factor VIII:C
AT391808B (de) * 1986-11-03 1990-12-10 Immuno Ag Verfahren zur herstellung einer faktor viii (ahf)-haeltigen fraktion
ATE112287T1 (de) * 1987-12-21 1994-10-15 Miles Inc Faktor viii- gelfiltration.
WO1989009784A1 (fr) * 1988-04-08 1989-10-19 Commonwealth Serum Laboratories Commission Production de concentre de facteur viii thermostable
ES2042138T3 (es) * 1989-05-24 1993-12-01 Miles Inc. Filtracion en gel del factor viii tratado termicamente.

Also Published As

Publication number Publication date
HUT60511A (en) 1992-09-28
ZA908599B (en) 1991-07-31
DK162233B (da) 1991-09-30
WO1991007438A1 (fr) 1991-05-30
FI103510B (fi) 1999-07-15
FI103510B1 (fi) 1999-07-15
IE904022A1 (en) 1991-05-22
IL96277A0 (en) 1991-08-16
DK562189A (da) 1991-05-10
DE69017050T2 (de) 1995-06-14
ES2068404T3 (es) 1995-04-16
NO180741C (no) 1997-06-11
EP0524172B1 (fr) 1995-02-15
PT95830B (pt) 1997-11-28
CA2073012A1 (fr) 1991-05-10
HU9201551D0 (en) 1992-08-28
NO180741B (no) 1997-03-03
YU47524B (sh) 1995-10-03
HU214905B (hu) 1998-07-28
CN1044121C (zh) 1999-07-14
CN1051732A (zh) 1991-05-29
DE69017050D1 (de) 1995-03-23
NO921839L (no) 1992-07-08
JP2509407B2 (ja) 1996-06-19
DK562189D0 (da) 1989-11-09
NO921839D0 (no) 1992-05-08
BG96316A (bg) 1993-12-24
SK278640B6 (en) 1997-12-10
PL287703A1 (en) 1991-12-02
FI922105A0 (fi) 1992-05-08
SK537190A3 (en) 1997-12-10
US5245014A (en) 1993-09-14
BG61231B1 (en) 1997-03-31
AU6747090A (en) 1991-06-13
IE66836B1 (en) 1996-02-07
CZ537190A3 (cs) 1998-05-13
PL164894B1 (pl) 1994-10-31
JPH05501557A (ja) 1993-03-25
UA29421C2 (uk) 2000-11-15
YU210590A (sh) 1993-05-28
RU2055593C1 (ru) 1996-03-10
PT95830A (pt) 1991-09-30
CA2073012C (fr) 1996-03-19
EP0524172A1 (fr) 1993-01-27
AU631471B2 (en) 1992-11-26
NZ236004A (en) 1991-11-26
FI922105A (fi) 1992-05-08
IL96277A (en) 1995-07-31
ATE118508T1 (de) 1995-03-15

Similar Documents

Publication Publication Date Title
DK162233C (da) Fremgangsmaade til isolering af faktor viii fra blodplasma og pharmaceutisk praeparat indeholdende den saaledes isolerede fator viii
NO174105C (no) Analogifremgangsmåte for fremstilling av antikoagulerende peptider
NZ218913A (en) Process for separating components of natural gas
DK442688D0 (da) Fremgangsmaade og praeparat til behandling af non-ige-medierede lidelser
DK0804070T3 (da) Fremgangsmåde til isolering af proteiner fra mælk
NO880866L (no) Apparat for separasjon av blodbestanddeler.
DK123387A (da) Fremgangsmaade til fjernelse af no fra fluoidumstroemme og middel til udfoerelse af fremgangsmaaden
DK125390D0 (da) Fremgangsmaade til fremstilling af ostemasse indeholdende valleprotein og fremgangsmaade til fremstilling af ost ud fra ostemassen
IT1228033B (it) Membrana semipermeabile di polibenzossazolo per la separazione di gas
ATE85345T1 (de) Neues cadiodilatin-fragment, prozess zu dessen herstellung und dessen anwendung.
GB2218991B (en) Enzymatic membrane method for the synthesis of peptides and the separation of optical isomers
PT87111A (pt) Process for the preparation of cyclic peptides and of pharmaceutical compositions containing the same
DK1036166T3 (da) Fremgangsmåde til ekstraktion af udklækningsvæske fra atlantisk laks og anvendelse af denne væske
AU7255687A (en) Improved process for separation of acid gases
DK0428984T3 (da) Fremgangsmåde til fraskillelse af aminosyrer
KR920701461A (ko) 펩티드의 합성 및 분리를 위한 효소막법
IT9020371A0 (it) Procedimento per la separazione di azoto da gas naturale
HK50691A (en) Enzymatic membrane method for the synthesis of peptides and the separation of optical isomers
NO161596C (no) Fremgangsmaate for gjenvinning av proteiner og andre naeringsstoffer fra proteinholdig vann.
DK690587A (da) Tetrapeptid, dets fremstilling og anvendelse
ATA264687A (de) Beta-lactamverbindungen, verfahren zu ihrer herstellung, dieselben enthaltende pharmazeutischepraeparate zur behandlung von durch bakterien verursachte infektionskrankheiten

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK